|
 Academic Year: | 2016/7 |
| Owning Department/School: | Department of Pharmacy & Pharmacology |
| Credits: | 6 [equivalent to 12 CATS credits] |
| Notional Study Hours: | 120 |
| Level: | Honours (FHEQ level 6) |
| Period: |
|
| Assessment Summary: | EX 100% |
| Assessment Detail: |
|
| Supplementary Assessment: |
|
| Requisites: | |
| Description:
| Aims: The aims of this unit are to provide a knowledge base of recent developments in understanding the cardivascular system and its role in human diseases, and to examine how such understanding can lead to identification and exploitation of novel drug targets for future therapy. Learning Outcomes: On successful completion of this unit, the student should be able to: demonstrate knowledge and understanding of recently identified target molecules and processes in the cardiovascular system, give examples of the role of these targets in particular therapeutic areas and utilise a range of ICT and cognitive skills in acquiring knowledge and understanding and applying them to given situations. Skills: Scientific skills (T/F/A) Study skills, handling information, working with others (T/F) Problem solving (T/F). Content: Following an introduction and brief overview of earlier core units, a number of topics will be discussed covering recent advances in cardiovascular pharmacology. Topics will be selected on the basis of their currency at a given time - examples may include regulation of blood vessel tone, calcium and potassium channels, endothelium-derived vasorelaxant factors, vascular disease, including stroke and pulmonary hypertension; blood platelet regulatory mechanisms, cardiac arrythmia and channelopathies, including long QT-syndrome. |
| Programme availability: |
PA30150 is Optional on the following programmes:Department of Pharmacy & Pharmacology
|
Notes:
|